These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12445159)

  • 1. Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease.
    Green AJ
    Neuropathol Appl Neurobiol; 2002 Dec; 28(6):427-40. PubMed ID: 12445159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.
    Abu Rumeileh S; Lattanzio F; Stanzani Maserati M; Rizzi R; Capellari S; Parchi P
    J Alzheimers Dis; 2017; 55(4):1471-1480. PubMed ID: 27886009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?
    Kapaki E; Kilidireas K; Paraskevas GP; Michalopoulou M; Patsouris E
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):401-3. PubMed ID: 11511720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease.
    Hermann P; Haller P; Goebel S; Bunck T; Schmidt C; Wiltfang J; Zerr I
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia.
    Karch A; Llorens F; Schmitz M; Arora AS; Zafar S; Lange P; Schmidt C; Zerr I
    J Alzheimers Dis; 2016 Oct; 54(4):1385-1393. PubMed ID: 27589519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.
    Dorey A; Tholance Y; Vighetto A; Perret-Liaudet A; Lachman I; Krolak-Salmon P; Wagner U; Struyfs H; De Deyn PP; El-Moualij B; Zorzi W; Meyronet D; Streichenberger N; Engelborghs S; Kovacs GG; Quadrio I
    JAMA Neurol; 2015 Mar; 72(3):267-75. PubMed ID: 25559883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease.
    Green AJ
    Biochem Soc Trans; 2002 Aug; 30(4):382-6. PubMed ID: 12196099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA differentiates Alzheimer's disease from Creutzfeldt-Jakob disease.
    Podlesniy P; Llorens F; Golanska E; Sikorska B; Liberski P; Zerr I; Trullas R
    Alzheimers Dement; 2016 May; 12(5):546-55. PubMed ID: 26806388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
    Riemenschneider M; Wagenpfeil S; Vanderstichele H; Otto M; Wiltfang J; Kretzschmar H; Vanmechelen E; Förstl H; Kurz A
    Mol Psychiatry; 2003 Mar; 8(3):343-7. PubMed ID: 12660807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease.
    Green AJ; Thompson EJ; Stewart GE; Zeidler M; McKenzie JM; MacLeod MA; Ironside JW; Will RG; Knight RS
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):744-8. PubMed ID: 11385008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease.
    Van Everbroeck B; Quoilin S; Boons J; Martin JJ; Cras P
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1210-4. PubMed ID: 12933920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
    Blennow K; Diaz-Lucena D; Zetterberg H; Villar-Pique A; Karch A; Vidal E; Hermann P; Schmitz M; Ferrer Abizanda I; Zerr I; Llorens F
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):846-853. PubMed ID: 31097472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
    Grangeon L; Paquet C; Bombois S; Quillard-Muraine M; Martinaud O; Bourre B; Lefaucheur R; Nicolas G; Dumurgier J; Gerardin E; Jan M; Laplanche JL; Peoc'h K; Hugon J; Pasquier F; Maltête D; Hannequin D; Wallon D;
    J Alzheimers Dis; 2016; 51(3):905-13. PubMed ID: 26890785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
    Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
    Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid Levels of 14-3-3 Gamma: What Does It Tell Us About Sporadic Creutzfeldt-Jakob Disease?
    Humpel C; Benke T
    Pharmacology; 2017; 100(5-6):243-245. PubMed ID: 28743115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease.
    Noguchi-Shinohara M; Hamaguchi T; Nozaki I; Sakai K; Yamada M
    J Neurol; 2011 Aug; 258(8):1464-8. PubMed ID: 21360196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
    Buerger K; Otto M; Teipel SJ; Zinkowski R; Blennow K; DeBernardis J; Kerkman D; Schröder J; Schönknecht P; Cepek L; McCulloch C; Möller HJ; Wiltfang J; Kretzschmar H; Hampel H
    Neurobiol Aging; 2006 Jan; 27(1):10-5. PubMed ID: 16298235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease cerebrospinal fluid biomarkers differentiate patients with Creutzfeldt-Jakob disease and autoimmune encephalitis.
    Chang BK; Day GS; Graff-Radford J; McKeon A; Flanagan EP; Algeciras-Schimnich A; Mielke MM; Nguyen A; Jones DT; Toledano M; Kremers WK; Knopman DS; Petersen RC; Li W
    Eur J Neurol; 2022 Oct; 29(10):2905-2912. PubMed ID: 35735602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of plasma brain-derived tau and p-tau181 in Alzheimer's disease and rapidly progressive dementias.
    Gonzalez-Ortiz F; Karikari TK; Bentivenga GM; Baiardi S; Mammana A; Turton M; Kac PR; Mastrangelo A; Harrison P; Capellari S; Zetterberg H; Blennow K; Parchi P
    Alzheimers Dement; 2024 Jan; 20(1):745-751. PubMed ID: 37858957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.
    Van Everbroeck B; Dobbeleir I; De Waele M; De Deyn P; Martin JJ; Cras P
    J Neurol; 2004 Mar; 251(3):298-304. PubMed ID: 15015009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.